Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
New research, which is being presented at a conference in Germany and has not been peer-reviewed, suggests that Eli Lilly's newer drug could be even more effective
Study CLBP-1: Two hundred thirty-six adult patients (N=115 on Duloxetine, N=121 on placebo) enrolled and 182 (77%) completed 13-week treatment phase
Some inherited metabolic disorders (pyridoxine-dependent conditions) may require very large daily doses
Lancet (2014) 384:134957
Call the number on the back of your UHC membership card to see if your plan is eligible for Real Appeal benefits
US$ 26.63
US$ 23.21
/media/img/mt/2024/10/GLP_1/original.jpg){kind=icon}
US$ 22.58
US$ 24.73
US$ 28.44
US$ 23.90
US$ 23.29
US$ 24.45
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
